Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine
Authors
Keywords
-
Journal
CELL CYCLE
Volume 11, Issue 23, Pages 4447-4461
Publisher
Informa UK Limited
Online
2012-11-30
DOI
10.4161/cc.22786
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breathing lessons: Tor tackles the mitochondria
- (2016) Toren Finkel Aging-US
- Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy
- (2016) Sean M. Armour et al. Aging-US
- Decision-making by p53 and mTOR
- (2016) Carl G. Maki Aging-US
- DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence
- (2016) Olga V. Leontieva et al. Aging-US
- Why men age faster but reproduce longer than women: mTOR and evolutionary perspectives
- (2016) Mikhail V. Blagosklonny Aging-US
- mTOR favors senescence over quiescence in p53-arrested cells
- (2016) Thaddeus T. Schug Aging-US
- STAT3, HIF-1, glucose addiction and Warburg effect
- (2016) James E. Darnell Aging-US
- Nutrient withdrawal rescues growth factor-deprived cells from mTOR-dependent damage
- (2016) Emiliano Panieri et al. Aging-US
- TP53 and MTOR crosstalk to regulate cellular senescence
- (2016) Lorenzo Galluzzi et al. Aging-US
- Why human lifespan is rapidly increasing: solving "longevity riddle" with "revealed-slow-aging" hypothesis
- (2016) Mikhail V. Blagosklonny Aging-US
- A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction
- (2016) Marco Demaria et al. Aging-US
- Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: Similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling"
- (2016) Stephanos Pavlides et al. Aging-US
- Be quiet and you'll keep young: does mTOR underlie p53 action in protecting against senescence by favoring quiescence?
- (2016) Vjekoslav Dulic Aging-US
- Normalizing a hyperactive mTOR initiates muscle growth during obesity
- (2016) David L. Williamson et al. Aging-US
- A role for Ras signaling in modulating mammalian aging by the GH/IGF1 axis
- (2016) João Pedro de Magalhães Aging-US
- mTOR pathway activation in age-related retinal disease
- (2016) Chen Zhao et al. Aging-US
- Insights from model organisms on the functions of the tumor suppressor protein LKB1: Zebrafish chips in
- (2016) Yme U. van der Velden et al. Aging-US
- Progeria, rapamycin and normal aging: recent breakthrough
- (2016) Mikhail V. Blagosklonny Aging-US
- Metformin and the ATM DNA damage response (DDR): Accelerating the onset of stress-induced senescence to boost protection against cancer
- (2016) Javier A. Menendez et al. Aging-US
- Epidermal growth factor and aging: A signaling molecule reveals a new eye opening function
- (2016) Christopher Rongo Aging-US
- Molecular damage in cancer: an argument for mTOR-driven aging
- (2016) Mikhail V. Blagosklonny Aging-US
- Yeast-like chronological senescence in mammalian cells: phenomenon, mechanism and pharmacological suppression
- (2016) Olga V. Leontieva et al. Aging-US
- Potential of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex
- (2016) Philippe Major Aging-US
- RasGrf1: genomic imprinting, VSELs, and aging
- (2016) Mariusz Z. Ratajczak et al. Aging-US
- Mutations in the BRCT binding site of BRCA1 result in hyper-recombination
- (2016) Seth M. Dever et al. Aging-US
- Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
- (2016) Linda S. Steelman et al. Aging-US
- Genome protective effect of metformin as revealed by reduced level of constitutive DNA damage signaling
- (2016) H. Dorota Halicka et al. Aging-US
- If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice
- (2016) Vladimir N. Anisimov et al. Aging-US
- Role of Pten in leukemia stem cells
- (2015) Oncotarget
- Targeting Rb mutant cancers by inactivating TSC2
- (2015) Oncotarget
- P3Kα: A Driver of Tumor Metastasis?
- (2015) Oncotarget
- PI3Kα Inhibitors That Inhibit Metastasis
- (2015) Oncotarget
- A new therapeutic basis for treating Li-Fraumeni Syndrome breast tumors expressing mutated TP53
- (2015) Oncotarget
- A beta version of life: p110β takes center stage
- (2015) Oncotarget
- Targeting the PI3K/Akt/mTOR Pathway – Beyond Rapalogs
- (2015) Oncotarget
- Will PI3K pathway inhibitors be effective as single agents in patients with cancer?
- (2015) Joan T. Garrett et al. Oncotarget
- AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications.
- (2015) Leonidas Platanias et al. Oncotarget
- Wiring the oncogenic circuitry: Pin1 unleashes mutant p53
- (2015) Oncotarget
- Using quantitative proteomic analysis to understand genotype specific intrinsic drug resistance in melanoma
- (2015) John M. Koomen et al. Oncotarget
- The beating heart of melanomas: a minor subset of cancer cells sustains tumor growth
- (2015) Patrick Schmidt et al. Oncotarget
- Targeting mTOR for the treatment of AML. New agents and new directions.
- (2015) Jessica K. Altman et al. Oncotarget
- Elevated PI3K signaling drives multiple Breast Cancer subtypes
- (2015) Jessica Adams et al. Oncotarget
- Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors
- (2015) Valeria G. Antico Arciuch et al. Oncotarget
- Metformin: Multi-faceted protection against cancer
- (2015) Sonia Del Barco et al. Oncotarget
- Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells
- (2015) Genevieve L. Weber et al. Oncotarget
- Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy
- (2015) Jean-Claude Chomel et al. Oncotarget
- Involvement of Akt-1 and mTOR in Sensitivity of Breast Cancer to Targeted Therapy
- (2015) Melissa L. Sokolosky et al. Oncotarget
- Cooperative Effects of Akt-1 and Raf-1 on the Induction of Cellular Senescence in Doxorubicin or Tamoxifen Treated Breast Cancer Cells
- (2015) Jackson R. Taylor et al. Oncotarget
- Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture
- (2015) Pasha Apontes et al. Oncotarget
- INPP4B: the New Kid on the PI3K Block
- (2015) Irina U. Agoulnik et al. Oncotarget
- Targeting Autophagy Addiction in Cancer
- (2015) Joseph D. Mancias et al. Oncotarget
- Targeting Mnks for Cancer Therapy
- (2015) Jinqiang Hou et al. Oncotarget
- Ras inhibition by FTS attenuates brain tumor growth in mice by direct antitumor activity and enhanced reactivity of cytotoxic lymphocytes
- (2015) Elizabeta Aizman et al. Oncotarget
- Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment
- (2015) Alberto M. Martelli et al. Oncotarget
- Epigenetic control of an oncogenic microRNA, miR-155, by BRCA1
- (2015) Oncotarget
- Novel targeted therapies for mantle cell lymphoma
- (2015) Lapo Alinari et al. Oncotarget
- Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades
- (2015) James Andrew McCubrey et al. Oncotarget
- Targeted therapy for hepatocellular carcinoma: novel agents on the horizon
- (2015) Melchiorre Cervello et al. Oncotarget
- Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels
- (2015) Daniela Bressanin et al. Oncotarget
- Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance
- (2015) James Andrew McCubrey et al. Oncotarget
- Abstract 4322: Iron increases the invasiveness of prostate cancer cells in vitro: Mechanisms and inhibition by the antioxidant ebselen
- (2012) Wenji Guo et al. CANCER RESEARCH
- Calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylates Raf-1 at serine 338 and mediates Ras-stimulated Raf-1 activation
- (2012) Marcella Salzano et al. CELL CYCLE
- Iron Chelators for the Treatment of Cancer
- (2012) Y. Yu et al. CURRENT MEDICINAL CHEMISTRY
- Sustained Antidiabetic Effects of a Berberine-Containing Chinese Herbal Medicine Through Regulation of Hepatic Gene Expression
- (2012) H.-L. Zhao et al. DIABETES
- Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies
- (2012) Alberto M Martelli et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia
- (2012) C Simioni et al. LEUKEMIA
- Passenger deletions generate therapeutic vulnerabilities in cancer
- (2012) Florian L. Muller et al. NATURE
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
- (2012) Timothy R. Wilson et al. NATURE
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
- (2012) Hiroshi Noto et al. PLoS One
- Novel Somatic Mutations to PI3K Pathway Genes in Metastatic Melanoma
- (2012) Austin Y. Shull et al. PLoS One
- Melanoma whole-exome sequencing identifies V600E B-RAF amplification-mediated acquired B-RAF inhibitor resistance
- (2012) Hubing Shi et al. Nature Communications
- Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression
- (2011) Hak-Su Kim et al. BIOCHEMICAL PHARMACOLOGY
- Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis
- (2011) Ana P. Gomes et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo
- (2011) Avishek Ganguly et al. BIOMETALS
- Mutant BRAF Melanomas—Dependence and Resistance
- (2011) Poulikos I. Poulikakos et al. CANCER CELL
- PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression
- (2011) K. H. T. Paraiso et al. CANCER RESEARCH
- Lipocalin 2: A multifaceted modulator of human cancer
- (2011) Jiang Yang et al. CELL CYCLE
- Regulation of activity and function of the p52 NF-κB subunit following DNA damage
- (2011) Benjamin Barré et al. CELL CYCLE
- CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitation
- (2011) Vivian Chen et al. CELL CYCLE
- Differences underlying EGFR and HER2 oncogene addiction
- (2011) Anthony C. Faber et al. CELL CYCLE
- mTOR goes to the nucleus
- (2011) Yu Jiang CELL CYCLE
- A growing family: Adding mutated Erbb4 as a novel cancer target
- (2011) Udo Rudloff et al. CELL CYCLE
- Dominant roles of the Raf/MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs
- (2011) Linda S. Steelman et al. CELL CYCLE
- Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo
- (2011) Vladimir N. Anisimov et al. CELL CYCLE
- Calorie restriction: Decelerating mTOR-driven aging from cells to organisms (including humans)
- (2011) Mikhail V Blagosklonny CELL CYCLE
- Metformin abolishes increased tumor18F-2-fluoro-2-deoxy-D-glucose uptake associated with a high energy diet
- (2011) Haider Mashhedi et al. CELL CYCLE
- Mechanism of hypoxia-induced NFκB
- (2011) Andrew Melvin et al. CELL CYCLE
- mTOR protein localization is cell cycle-regulated
- (2011) Margit Rosner et al. CELL CYCLE
- RB1 and p53 at the crossroad of EMT and triple-negative breast cancer
- (2011) Zhe Jiang et al. CELL CYCLE
- MiRegulators in cancer stem cells of solid tumors
- (2011) Stephanie Ma et al. CELL CYCLE
- Understanding PLZF
- (2011) Marina Kolesnichenko et al. CELL CYCLE
- Stat1 is a suppressor of ErbB2/Neu-mediated cellular transformation and mouse mammary gland tumor formation
- (2011) Jennifer F. Raven et al. CELL CYCLE
- Vitamin D
- (2011) Thomas S. Lisse et al. CELL CYCLE
- Reversing the Warburg effect through stromal autophagy
- (2011) Adam D. Richardson et al. CELL CYCLE
- Cooperative control of tumor suppressor genes by a network of oncogenic microRNAs
- (2011) Konstantinos J. Mavrakis et al. CELL CYCLE
- The tumor suppressor tuberin regulates mitotic onset through the cellular localization of cyclin B1
- (2011) Elizabeth Fidalgo da Silva et al. CELL CYCLE
- Metformin activates an Ataxia Telangiectasia Mutated (ATM)/Chk2-regulated DNA damage-like response
- (2011) Alejandro Vazquez-Martin et al. CELL CYCLE
- Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: Induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a
- (2011) Cristina Oliveras-Ferraros et al. CELL CYCLE
- LKB1/AMPK/mTOR signaling pathway in hematological malignancies: From metabolism to cancer cell biology
- (2011) Alexa S. Green et al. CELL CYCLE
- MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer
- (2011) Jelena Radojicic et al. CELL CYCLE
- A non-functional retinoblastoma tumor suppressor (RB) pathway in premenopausal breast cancer is associated with resistance to tamoxifen
- (2011) Sophie Lehn et al. CELL CYCLE
- Impact ofBCR-ABLmutations on patients with chronic myeloid leukemia
- (2011) Andreas Hochhaus et al. CELL CYCLE
- Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells
- (2011) Linda S. Steelman et al. CELL CYCLE
- Bioenergy sensing in the brain
- (2011) Stephen Amato et al. CELL CYCLE
- Polo-like kinase 1 regulates activation of AMP-activated protein kinase (AMPK) at the mitotic apparatus
- (2011) Alejandro Vazquez-Martin et al. CELL CYCLE
- Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16ink4a
- (2011) Martin Kosar et al. CELL CYCLE
- Insulin resistance due to nutrient excess
- (2011) Asish K. Saha et al. CELL CYCLE
- Antagonistic control of muscle cell size by AMPK and mTORC1
- (2011) Rémi Mounier et al. CELL CYCLE
- Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer
- (2011) Ubaldo E. Martinez-Outschoorn et al. CELL CYCLE
- NGAL Expression Is Elevated in Both Colorectal Adenoma-Carcinoma Sequence and Cancer Progression and Enhances Tumorigenesis in Xenograft Mouse Models
- (2011) Y. Sun et al. CLINICAL CANCER RESEARCH
- Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways
- (2011) James A. McCubrey et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
- (2011) Nikhil Wagle et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia
- (2011) C Evangelisti et al. LEUKEMIA
- Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway
- (2011) A M Martelli et al. LEUKEMIA
- AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications
- (2011) C Grimaldi et al. LEUKEMIA
- Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy
- (2011) L S Steelman et al. LEUKEMIA
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
- (2011) Poulikos I. Poulikakos et al. NATURE
- Prostate cancer outcome and tissue levels of metal ions
- (2011) Andrey G. Sarafanov et al. PROSTATE
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
- (2010) Jessie Villanueva et al. CANCER CELL
- RB in breast cancer
- (2010) Elizabeth A. Musgrove et al. CELL CYCLE
- AMPK: A metabolic checkpoint that regulates the growth of EGFR activated glioblastomas
- (2010) Deliang Guo et al. CELL CYCLE
- HdmX overexpression inhibits oncogene induced cellular senescence
- (2010) Kelly R. Miller et al. CELL CYCLE
- The autophagic tumor stroma model of cancer
- (2010) Stephanos Pavlides et al. CELL CYCLE
- RB-pathway disruption in breast cancer
- (2010) Adam Ertel et al. CELL CYCLE
- Pathways of oncogene-induced senescence in human melanocytic cells
- (2010) Rajat Bansal et al. CELL CYCLE
- The AMPK-FoxO3A axis as a target for cancer treatment
- (2010) Fulvio Chiacchiera et al. CELL CYCLE
- Both lipid- and protein-phosphatase activities of PTEN contribute to the p53-PTEN anti-invasion pathway
- (2010) Jacquelyne S. Poon et al. CELL CYCLE
- Double trouble: When Sonic hedgehog signaling meets TSC inactivation
- (2010) Bobby Bhatia et al. CELL CYCLE
- TACC3-TSC2 maintains nuclear envelope structure and controls cell division
- (2010) Laia Gómez-Baldó et al. CELL CYCLE
- Myc, Cdk2 and cellular senescence: Old players, new game
- (2010) Stefano Campaner et al. CELL CYCLE
- Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis
- (2010) Sílvia Cufí et al. CELL CYCLE
- The EphB2 tumor suppressor induces autophagic cell death via concomitant activation of the ERK1/2 and PI3K pathways
- (2010) Mustapha Kandouz et al. CELL CYCLE
- AKT-ing via microRNA
- (2010) Danish Sayed et al. CELL CYCLE
- The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy
- (2010) Stephen L. Abrams et al. CELL CYCLE
- Autophagy in cancer associated fibroblasts promotes tumor cell survival
- (2010) Ubaldo E. Martinez-Outschoorn et al. CELL CYCLE
- miR-31: A crucial overseer of tumor metastasis and other emerging roles
- (2010) Scott Valastyan et al. CELL CYCLE
- p85 plays a critical role in controlling flux through the PI3K/PTEN signaling axis through dual regulation of both p110 (PI3K) and PTEN
- (2010) Deborah H. Anderson CELL CYCLE
- microRNA-451: A conditional switch controlling glioma cell proliferation and migration
- (2010) Jakub Godlewski et al. CELL CYCLE
- Metformin regulates breast cancer stem cello ntogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
- (2010) Alejandro Vazquez-Martin et al. CELL CYCLE
- Metformin and cancer: Doses, mechanisms and the dandelion and hormetic phenomena
- (2010) Begoña Martin-Castillo et al. CELL CYCLE
- Relationships of lipocalin 2 with breast tumorigenesis and metastasis
- (2010) Xiaohong Leng et al. JOURNAL OF CELLULAR PHYSIOLOGY
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
- (2010) Cory M. Johannessen et al. NATURE
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Iron traffics in circulation bound to a siderocalin (Ngal)–catechol complex
- (2010) Guanhu Bao et al. Nature Chemical Biology
- BRAF Gene Amplification Can Promote Acquired Resistance to MEK Inhibitors in Cancer Cells Harboring the BRAF V600E Mutation
- (2010) R. B. Corcoran et al. Science Signaling
- Gatekeeper Mutations Mediate Resistance to BRAF-Targeted Therapies
- (2010) S. Whittaker et al. Science Translational Medicine
- Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
- (2009) Douglas B Kell BMC Medical Genomics
- Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: A new protein enters the scene
- (2009) Davide Bolignano et al. CANCER LETTERS
- Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis
- (2009) X. Leng et al. CANCER RESEARCH
- Matrix Metalloproteinases As Novel Biomarker s and Potential Therapeutic Targets in Human Cancer
- (2009) Roopali Roy et al. JOURNAL OF CLINICAL ONCOLOGY
- NGAL decreases E-cadherin-mediated cell–cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells
- (2009) Limei Hu et al. LABORATORY INVESTIGATION
- Lipocalin 2 promotes breast cancer progression
- (2009) J. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The TGF-β, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer
- (2008) Stephen J. Assinder et al. BIOCHEMICAL JOURNAL
- The iron-regulated metastasis suppressor, Ndrg-1: Identification of novel molecular targets
- (2008) Zaklina Kovacevic et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Genetic Predictors of MEK Dependence in Non-Small Cell Lung Cancer
- (2008) C. A. Pratilas et al. CANCER RESEARCH
- Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy
- (2008) E. R. Smith et al. CLINICAL CANCER RESEARCH
- Tumor-Specific Urinary Matrix Metalloproteinase Fingerprinting: Identification of High Molecular Weight Urinary Matrix Metalloproteinase Species
- (2008) R. Roy et al. CLINICAL CANCER RESEARCH
- Urine Biomarkers May Someday Detect Even Distant Tumors
- (2008) C. Schmidt JNCI-Journal of the National Cancer Institute
- Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas
- (2008) K. S.M. Smalley et al. MOLECULAR CANCER THERAPEUTICS
- AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
- (2008) Dana M. Gwinn et al. MOLECULAR CELL
- The neutrophil gelatinase-associated lipocalin (NGAL), a NF- B-regulated gene, is a survival factor for thyroid neoplastic cells
- (2008) A. Iannetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now